{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:08:28Z","timestamp":1793725708460,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020207","name":"Health Commission of Sichuan Province","doi-asserted-by":"publisher","award":["25LCYJ52"],"award-info":[{"award-number":["25LCYJ52"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["25LHYW2-03"],"award-info":[{"award-number":["25LHYW2-03"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["25LHSFY3-60"],"award-info":[{"award-number":["25LHSFY3-60"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["CYZYB25-03"],"award-info":[{"award-number":["CYZYB25-03"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["CYZYB24-20"],"award-info":[{"award-number":["CYZYB24-20"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["CYFY-GQ77"],"award-info":[{"award-number":["CYFY-GQ77"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2026NSFSC1849"],"award-info":[{"award-number":["2026NSFSC1849"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejphar.2026.178830","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:34:55Z","timestamp":1774658095000},"page":"178830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Deacetylasperulosidic acid methyl ester attenuates liver fibrosis by modulating the SCFAs-Wnt\/\u03b2-catenin signaling axis"],"prefix":"10.1016","volume":"1021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-8027","authenticated-orcid":false,"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178830_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178830_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178830_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Ayd\u0131n","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.178830_bib4","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1002\/wsbm.1499","article-title":"Liver fibrosis: pathophysiology and clinical implications","volume":"13","author":"Berumen","year":"2021","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.ejphar.2026.178830_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2174\/1389557522666220816130158","article-title":"Iridoids as a potential hepatoprotective class: a review","volume":"23","author":"Bridi","year":"2023","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178830_bib6","article-title":"Astragaloside IV as a promising therapeutic agent for liver diseases: current landscape and future perspectives","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178830_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10753-025-02407-0","article-title":"Deacetylasperulosidic acid methyl ester ameliorates carbon tetrachloride-induced liver fibrosis by suppressing inflammation and modulating gut microbiota","volume":"49","author":"Chen","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2026.178830_bib8","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1039\/D3TB02790B","article-title":"Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents","volume":"12","author":"Chen","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejphar.2026.178830_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10238-022-00799-z","article-title":"Liver biopsy for assessment of chronic liver diseases: a synopsis","volume":"23","author":"Chowdhury","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ejphar.2026.178830_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/10937404.2023.2220147","article-title":"Evaluation of the carcinogenicity of carbon tetrachloride","volume":"26","author":"Cohen","year":"2023","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.ejphar.2026.178830_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137379","article-title":"The role of short chain fatty acids in inflammation and body health","volume":"25","author":"Du","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178830_bib12","first-page":"960","article-title":"Targeting the wnt signaling pathway in liver fibrosis for drug options: an update","volume":"9","author":"Duspara","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178830_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108517","article-title":"SCFAs switch stem cell fate through HDAC inhibition to improve barrier integrity in 3D intestinal organoids from patients with obesity","volume":"26","author":"Farhadipour","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ejphar.2026.178830_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10555-023-10117-y","article-title":"Short-chain fatty acids in cancer pathogenesis","volume":"42","author":"Feitelson","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejphar.2026.178830_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121954","article-title":"Butyrate protects against diet-induced NASH and liver fibrosis and suppresses specific non-canonical TGF-\u03b2 signaling pathways in human hepatic stellate cells","volume":"9","author":"Gart","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.178830_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-pharmtox-020524-012013","article-title":"Immunoregulation of liver fibrosis: new opportunities for antifibrotic therapy","volume":"65","author":"Gilgenkrantz","year":"2025","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.178830_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.33160\/yam.2025.05.009","article-title":"The Wnt\/\u03b2-Catenin inhibitor HC-1 suppresses liver fibrosis by inhibiting activated hepatic stellate cells and inducing matrix Metalloproteinase-1","volume":"68","author":"Hatakeyama","year":"2025","journal-title":"Yonago Acta Med."},{"key":"10.1016\/j.ejphar.2026.178830_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2393270","article-title":"The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease","volume":"16","author":"Hays","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejphar.2026.178830_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejphar.2026.178830_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1644758","article-title":"Gut microbiota-derived metabolites in keloid and hypertrophic scarring","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejphar.2026.178830_bib21","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2026.178830_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178830_bib23","doi-asserted-by":"crossref","first-page":"31342","DOI":"10.18632\/oncotarget.25809","article-title":"A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells","volume":"9","author":"Kobayashi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2026.178830_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fphar.2018.00533","article-title":"The anti-inflammatory effects of short chain fatty acids on Lipopolysaccharide- or tumor necrosis factor \u03b1-Stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178830_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00018-024-05532-5","article-title":"Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2026.178830_bib26","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s40265-019-01126-9","article-title":"Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities","volume":"79","author":"Manka","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2026.178830_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2026.178830_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0029665120006916","article-title":"SCFA: mechanisms and functional importance in the gut","volume":"80","author":"Martin-Gallausiaux","year":"2021","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.ejphar.2026.178830_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216502","article-title":"Gut microbiota and bacterial translocation in the pathogenesis of liver fibrosis","volume":"24","author":"Maslennikov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178830_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178830_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1248\/bpb.19.160","article-title":"Hypoglycemic activity and structure-activity relationship of iridoidal glycosides","volume":"19","author":"Miura","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2026.178830_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103103","article-title":"Wnt\/\u03b2-Catenin signaling as a potential target for the treatment of liver cirrhosis using antifibrotic drugs","volume":"19","author":"Nishikawa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178830_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116641","article-title":"Methanolic extract of O.umbellata L. exhibits anti-osteoporotic effect via promoting osteoblast proliferation in MG-63 cells and inhibiting osteoclastogenesis in RANKL-stimulated RAW 264.7 cells","volume":"315","author":"Paramasivam","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.178830_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejphar.2026.178830_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","article-title":"Wnt-\u03b2-catenin signalling in liver development, health and disease","volume":"16","author":"Perugorria","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178830_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.ejphar.2026.178830_bib37","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2026.178830_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1515\/reveh-2020-0048","article-title":"Toxicity of carbon tetrachloride, free radicals and role of antioxidants","volume":"36","author":"Unsal","year":"2021","journal-title":"Rev. Environ. Health"},{"key":"10.1016\/j.ejphar.2026.178830_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1508060","article-title":"Apigenin as an emerging hepatoprotective agent: current status and future perspectives","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178830_bib40","article-title":"Iridoids: research advances in their phytochemistry, biological activities, and pharmacokinetics","volume":"25","author":"Wang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178830_bib41","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10753-023-01826-1","article-title":"Phillygenin ameliorates carbon tetrachloride-induced liver fibrosis: suppression of inflammation and Wnt\/\u03b2-Catenin signaling pathway","volume":"46","author":"Wang","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2026.178830_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2026.121450","article-title":"Hedyotis diffusa willd. extract alleviates CCl(4)-induced liver fibrosis via modulation of the gut microbiota and FXR\/SHP\/CYP7A1-mediated bile acid metabolism","volume":"363","author":"Wang","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.178830_bib43","article-title":"Phillygenin attenuates carbon tetrachloride-induced liver fibrosis via modulating inflammation and gut microbiota","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178830_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115478","article-title":"Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism","volume":"296","author":"Wang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.178830_bib45","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.2174\/0109298673288458240203064112","article-title":"Natural products in liver fibrosis management: a five-year review","volume":"31","author":"Wang","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178830_bib46","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S577265","article-title":"Matrine in liver diseases: mechanistic insights and therapeutic potential","volume":"20","author":"Wen","year":"2026","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2026.178830_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MEG.0000000000002483","article-title":"A review of edible plant-derived natural compounds for the therapy of liver fibrosis","volume":"35","author":"Xu","year":"2023","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178830_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154517","article-title":"Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice","volume":"108","author":"Xue","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.178830_bib49","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.7150\/thno.106597","article-title":"Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2026.178830_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2026.178830_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202200597","article-title":"Butyrate attenuates hepatic steatosis induced by a high-fat and fiber-deficient diet via the hepatic GPR41\/43-CaMKII\/HDAC1-CREB pathway","volume":"67","author":"Zheng","year":"2023","journal-title":"Mol. Nutr. Food Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:51:21Z","timestamp":1778633481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926003122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"alternative-id":["S0014299926003122"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178830","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deacetylasperulosidic acid methyl ester attenuates liver fibrosis by modulating the SCFAs-Wnt\/\u03b2-catenin signaling axis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178830"}}